Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 39.49$. Average daily volumn in 3 months 24.18M. Market cap 212.26B



Stock symbol : PFE. Exchange : NYSE. Currency : USD
Lastest price : 37.60$. Total volume : 20.23M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Pfizer Inc. (PFE)
Last Price
37.60$
Change
-0.23
Volume
20.23M

Previous Close37.83
Open38.04
Day Range37.56-38.44
Bid37.60 x 2.9k
Ask37.85 x 1k
Volume20.23M
Average Volume24.18M
Market Cap212.26B
Beta0.59
52 Week Range36.17-54.93
Trailing P/E7.42
Foward P/E10.74
Dividend (Yield %)4.36%
Ex-Dividend Date2023-05-11



Financial Details


According to Pfizer Inc.'s financial reports the company's revenue in 2022 were 100.33B an decrease( +23.46%) over the years 2021 revenue that were of 81.29B. In 2022 the company's total earnings were 31.37B while total earnings in 2021 were 21.98B( +47.62%).


Loading ...



Organization

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRN... A and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Market Cap:
212.26B
Revenue:
100.33B
Total Assets:
197.21B
Total Cash:
416M



News about "Pfizer Inc."

pfizer inc.

Source from : Fox Business - 6 days ago

Pfizer Inc and BioNTech's COVID vaccine was approved for use in children under 5 years old in June, and new studies have shown the vaccine to be 73.2% effective within that age group.See details»


Pfizer Inc.: Novo Nordisk and Eli Lilly Lead Potential $60 Billion Obesity Drug Market; Valuations Look Rich

Source from : YAHOO!Finance - 4 days ago

Find the latest Pfizer, Inc. (PFE) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»


pfizer-inc-pfe-shares-up-despite-recent-market-volatility-image

Pfizer Inc. (PFE) Shares Up Despite Recent Market Volatility

Source from : newsheater - 3 month ago

Pfizer Inc. (NYSE: PFE)’s stock price has increased by 0.79 compared to its previous closing price of 36.48. However, the company has seen a -1.55% decrease in its stock price over the last five ...See details»


Pfizer Inc. (NYSE:PFE) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Source from : Yahoo Finance - 22 days ago

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Pfizer Inc. (NYSE:PFE) is about to go ex-dividend in ...See details»


Pfizer Inc (PFE): Today's Featured Drugs Laggard

Source from : TheStreet.com - 9 days ago

Pfizer was a leading decliner within the drugs industry, falling 31 cents (-1.1%) to $27.94 on average volume. Pfizer was a leading decliner within the drugs industry, falling 31 cents (-1.1%) to ...See details»


Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Source from : Nasdaq - 1 month ago

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...See details»


Pfizer Inc. (PFE) Q1 2023 Earnings Call Transcript

Source from : Seeking Alpha - 27 days ago

Good day, everyone, and welcome to Pfizer's First Quarter 2023 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo ...See details»


Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Tuesday Trading

Source from : The Buffalo News - 6 days ago

Pfizer Inc. (NYSE: PFE) is one today’s most active stocks by volume. So far today, approximately 23.87M shares of Pfizer Inc. have been exchanged, as compared to an average 30-day volume of 21.5M ...See details»


Will Pfizer Inc. (PFE) Underperform the Rest of the Stocks in the Healthcare Sector?

Source from : Benzinga.com - 1 month ago

The 45 rating InvestorsObserver gives to Pfizer Inc. (PFE) stock puts it near the middle of the Healthcare sector.In addition to scoring higher than 48 percent of stocks in the Healthcare sector ...See details»


Pfizer Inc.

Source from : Wall Street Journal - 1 month ago

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»


Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Monday Trading

Source from : The Buffalo News - 7 days ago

Pfizer Inc. (NYSE: PFE) is one today’s most active stocks by volume. So far today, approximately 44.05M shares of Pfizer Inc. have been exchanged, as compared to an average 30-day volume of 21.5M ...See details»


Pfizer Inc. (NYSE:PFE) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Source from : Yahoo News UK - 23 days ago

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Pfizer Inc. (NYSE:PFE) is about to go ex-dividend in just 4 ...See details»


41. Pfizer Inc.

Source from : Business Travel News - 2 years ago

Pfizer's revenue totaled $51.8 billion in 2019, down from $53.6 billion in 2018. The pharmaceutical company's U.S. air-booked volume was $95.2 million in 2019, an increase from $86.5 million in 2018.See details»


Pfizer Inc. (NYSE:PFE) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Source from : Yahoo Style UK - 23 days ago

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Pfizer Inc. (NYSE:PFE) is about to go ex-dividend in just 4 ...See details»